New Set of Isobaric Labeling Reagents for Quantitative 16Plex Proteomics.


Journal

Analytical chemistry
ISSN: 1520-6882
Titre abrégé: Anal Chem
Pays: United States
ID NLM: 0370536

Informations de publication

Date de publication:
04 04 2023
Historique:
medline: 5 4 2023
pubmed: 24 3 2023
entrez: 23 3 2023
Statut: ppublish

Résumé

Peptide labeling by isobaric tags is a powerful approach for the relative quantitative analysis of proteomes in multiple groups. There has been a revolution in the innovation of new isobaric reagents; however, great effort is being made to expand simultaneous labeling groups to identify more labeled peptides and reduce reporter ion signal suppression. We redesigned the original chemical structure of the deuterium isobaric amine-reactive tag developed in our laboratory. We optimized the synthetic pathway to create a new set of 16-plex isobaric tags (IBT-16plex). The novel reagent enabled almost complete labeling of peptides within 90 min, with all labeling reporter ions exhibiting comparable MS/MS signals. Compared to a typical 16plex reagent, TMTpro-16plex, the peptides and proteins identified by IBT-16plex in trypsinized HeLa cells were significantly increased by 14.8 and 8.6%, respectively. Moreover, differences in peptide abundance within 10-fold among multiple groups were barely suppressed in IBT-16plex, whereas the dynamic range in TMTpro-16plex-labeled groups was smaller. After quantitative examination of MCF7 cell proteins, IBT-16plex was confirmed as feasible and useful for evaluating protein responses of glucose-starved MCF7 cells to a glucose-rich medium.

Identifiants

pubmed: 36958307
doi: 10.1021/acs.analchem.3c00235
doi:

Substances chimiques

Indicators and Reagents 0
Peptides 0
Proteome 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5788-5795

Auteurs

Xiaolian Ning (X)

College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China.
BGI-Shenzhen, Shenzhen, Guangdong 518083, China.

Qidan Li (Q)

BGI-Shenzhen, Shenzhen, Guangdong 518083, China.

Jin Zi (J)

BGI-Shenzhen, Shenzhen, Guangdong 518083, China.
Zhejiang Cancer Hospital, Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Zhejiang, Hangzhou 310022, China.

Zhanlong Mei (Z)

BGI-Shenzhen, Shenzhen, Guangdong 518083, China.

Jie Liu (J)

BGI-Shenzhen, Shenzhen, Guangdong 518083, China.

Yuxing Zhang (Y)

BGI-Shenzhen, Shenzhen, Guangdong 518083, China.

Mao Bi (M)

School of Life Sciences, Department of Biology, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China.

Yan Ren (Y)

Zhejiang Cancer Hospital, Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Zhejiang, Hangzhou 310022, China.
Experiment Center for Science and Technology, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.

Xingang Liu (X)

Nanjing Apollomics Biotech Inc., Nanjing, Jiangsu 210033, China.

Chao Lv (C)

Nanjing Apollomics Biotech Inc., Nanjing, Jiangsu 210033, China.

Hequan Yao (H)

China Pharmaceutical University, Nanjing, Jiangsu 210009, China.

Jianguo Sun (J)

China Pharmaceutical University, Nanjing, Jiangsu 210009, China.

Feng Rao (F)

School of Life Sciences, Department of Biology, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China.

Shuwei Li (S)

Nanjing Apollomics Biotech Inc., Nanjing, Jiangsu 210033, China.
China Pharmaceutical University, Nanjing, Jiangsu 210009, China.

Siqi Liu (S)

BGI-Shenzhen, Shenzhen, Guangdong 518083, China.
Zhejiang Cancer Hospital, Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Zhejiang, Hangzhou 310022, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH